Dark matter is a mysterious substance composing most of the material universe, now widely thought to be some form of massive exotic particle. An intriguing alternative view is that dark matter is made of black holes formed during the first second of our universe’s existence, known as primordial black holes.
Demo of lifelike interactive digital artist performance. This demo showcases one of the immediate possible applications for Mixed Reality.
We have brought to life a highly realistic, detailed character who performs for and interacts with users, while being rendered purely in real time on untethered mobile devices.
LIFELIKE DIGITAL CHARACTERS
What humans will look like in 100 years: Expert reveals the genetically modified bodies we’ll need to survive
- Harvard researchers says to survive the next extinction we must leave the Earth
- But to live on other planets we will need to genetically modify our organs
- Experts have previously speculated how humanity will look in 1,000 years’ time
- Video describes scenario in which bodies are part-human part-machine
By Harry Pettit For Mailonline
Here are all 11 “Imagining” videos I’ve published. You can click on the buttons along the top to jump to any particular dimension whenever you want, or if you’ve got an hour and forty-four minutes to spare watch the whole thing! As always, please go to www.tenthdimension.com/blog for the latest about this project, or subscribe to me at twitter.com/10thdim
And thank you everyone for your continued support! We’ve now passed 27,000 subscribers, and youtube estimates that my videos have been watched on this channel for over 31 million minutes. That’s incredible!
David Brin: “Stephen Hawking writes that rising inequality makes this the most dangerous time for our planet. Why? In America and the West, inequality has only been rising (at accelerating rates) for a few decades, from its lowest levels in human history. 99% of our ancestors lived in far steeper hierarchies. So, in a sense, what’s the fuss?”
“Simple. The vast creativity of a middle class society made us so productive we could avoid a Malthusian collapse. But if we return to feudalism — as our New Oligarchs intend — then all of that will collapse. But seven billions won’t go down quietly. A billion of them have vast technological tools and skills that would make Robspierre, Lenin, Mao or Osama gulp with envy. You do NOT want to see the technical castes radicalize…”
“… yet that is exactly what the Murdoch-Koch + foreign oligarchs seem to have in mind. And that is why rising inequality is an existential threat to all humanity. Because we are led by conniving oligarchs who are clearly way, way less smart than they think they are. “.
To understand if the world is getting worse you have to look at the past data to see. So many people suggest we are heading for dystopia especially when talking about increased lifespans through technology but this doesnt really measure up against the facts. Life has never been so good and worth fighting for!
A common objection to increased lifespans is that the world is either already a horrible place or heading into some kind of sci-fiction dystopia not worth living. There are problems in the world but this article shows just how much science and technology has improved lives for decades.
The truth is there are problems in the world but nothing that we cannot overcome if we try. The world is a wonderful place, there is every reason to want to be alive and experience it and technology could let us live longer to enjoy it even more.
“Freedom is impossible without faith in free people. And if we are not aware of our history and falsely believe the opposite of what is true we risk losing faith in each other.”
More progress in treating MS.
In findings that show the effectiveness of a new strategy for treating multiple sclerosis (MS), researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab (brand name Ocrevus) in both relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
The trial results are published online on Dec. 21, 2016, in The New England Journal of Medicine (NEJM), and are discussed in an accompanying editorial.
In multiple sclerosis, the immune system attacks the body, making it a so-called autoimmune disease. To date, all MS drugs have targeted the immune system’s T cells. Ocrelizumab, in contrast, depletes populations of the immune system’s B cells.